Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q96FX7 (
tRNA
)
26,753
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Samples of
tRNA
isolated from the cell sap of full-term human placenta were found to have a low capacity for accepting amino acids in the presence of partially purified synthetase preparations made from placental or rat liver cell sap.
Gel
electrophoresis of placental
tRNA
showed that part of this could be accounted for by gross degradation. The proportion of chargeable
tRNA
carrying amino acids was estimated by periodate oxidation followed by stripping and then charging with labeled amino acids. Only 50% of chargeable placental
tRNA
was in the charged state when isolated, whereas 87% of freshly isolated rat liver
tRNA
was found to be charged with amino acids. A fraction from placental cell sap was shown to have tRNA nucleotidyltransferase activity. When placental
tRNA
was incubated with this fraction and [3H]ATP or [3H]CTP, ATP was incorporated into about 12% of the
tRNA
molecules and CTP into 5-7%. When rat liver
tRNA
was used in place of placental
tRNA
, [3H]ATP was incorporated into less than 5% of the
tRNA
molecules. By using snake-venom diesterase over short periods of incubation, it was confirmed that the ATP had been incorporated terminally as AMP into the placental
tRNA
. These observations show that, in contrast to rat liver
tRNA
,
tRNA
prepared from human placenta is poorly charged with amino acids, many of the molecules lack the acceptor trinucleotide and there is extensive degradation beyond this stage.
...
PMID:Status of tRNA charging, trinucleotide acceptor sequence and tRNA nucleotidyltransferase activity in the human placenta. 18 40
The histidyl-tRNA synthetase of rabbit reticulocyte cytosol has been purified 84 000-fold to apparent homogeneity with a specific activity of 687 nmol of histidyl-
tRNA
formed per min per mg of protein. Ten to 15% of the enzyme activity is sedimented with the ribosomes while the remainder is in the cytosol. The purified enzyme has a molecular weight of 122 000 as determined by sucrose density gradient centrifugation.
Gel
electrophoresis in the presence of 0.1% sodium dodecyl sulfate suggests that it is composed of two similar subunits with a molecular weight of approximately 64 000. The enzyme has a magnesium optimum of 45 mM; however, this is reduced to 5 mM in the presence of an intracellular potassium concentration (160 nM). The enzyme acylates the two histidine
tRNA
isoacceptors of rabbit reticulocytes with similar Km values and at similar rates.
...
PMID:Purification and some properties of the histidyl-tRNA synthetase from the cytosol of rabbit reticulocytes. 24 47
Epithelial glycoprotein like that produced by the gastric surface consists of a polypeptide chain rich in serine and threonine; to these amino acid residues oligosaccharide chains of variable length are linked. The linking sugar is acetylgalactosamine. To find out whether the initial glycosylation takes place at the ribosomal level. I treated purified peptidyl-
tRNA
, derived from rat gastric membrane-bound polysomes, with alkali in the presence of boro[3H]hydride. Alkali specifically splits glycosidic bonds between serine or threonine and oligosaccharide side chains (beta-elimination reaction). The linking sugar is converted to an alditol and simultaneously labeled. GalNAc was identified as the linking sugar by paper chromatography. Furthermore, nascent peptides with lengths between 40 and 60 amino acid residues already contained this linking sugar.
Gel
filtration on Bio-
Gel
P-2 of 3H-labeled saccharides revealed that nascent chains contained mainly monosaccharides, but some di- or trisaccharides were found with GalNAc as the linkage sugar. These findings demonstrate that initial glycosylation of epithelial glycoprotein occurs at the ribosomal level rather shortly after the nascent peptide chain has reached the cisternal lumen of the endoplasmic reticulum.
...
PMID:Initial glycosylation of proteins with acetylgalactosaminylserine linkages. 28 57
Purification of rat liver tyrosine
tRNA
synthetase yields two protein fractions A and B and both fractions are required for charging of tyrosine to tRNAtyr. Fraction B catalyzes the activation of tyrosine. Fractions A and B have been purified to near homogeneity and they are composed of single polypeptide chains of 62,000 daltons each.
Gel
filtration studies suggest a molecular weight of 120,000 for the synthetase.
...
PMID:Purification and properties of tyrosyl tRNA synthetase of rat liver. 59 93
Rabbit liver
tRNA
nucleotidyldransferase bound to columns of Affi-
Gel
Blue and could be specifically eluted with
tRNA
. This observation led to development of a rapid purification procedure for the enzyme. The adsorbent was also used to assess interaction of tRNA nucleotidyltransferase with various polynucleotides and substrates. The enzyme could be efficiently desorbed from Affi-
Gel
Blue by low concentrations of
tRNA
-C-C, less well by
tRNA
-C-C-A, and not at all by poly(A), poly(C), ATP or CTP.
...
PMID:Binding of tRNA nucleotidyltransferase to Affi-Gel Blue: rapid purification of the enzyme and binding studies. 67 41
Unfractionated Escherichia coli
tRNA
has been aminoacylated with lysine and preferentially acetylated at the epsilon-amino nitrogen of lysine by reaction with N-acetoxysuccinimide. After treatment with peptidyl-tRNA hydrolase, 90% of the aminoacylated
tRNA
molecules were Nepsilon-acetyl-Lys-
tRNA
. Post-ribosomal supernatant enzymes would not deacylate Nepsilon-acetyl-Lys-
tRNA
in the presence of AMP and PPi, even though such mixed enzymes could acylate, with lysine,
tRNA
which had been exposed to the acetylation reaction conditions. Poly(rA) stimulated the binding of Nepsilon-acetyl-Lys-
tRNA
to E. coli ribosomes. At the ribosome and
tRNA
concentrations used, Nepsilon-acetyl-Lys-
tRNA
was bound nearly as well as Lys-
tRNA
at 30 mM Mg2+; at 10 mM Mg2+, the analogue was bound one-half as well as Lys-
tRNA
. Both Lys-
tRNA
and Nepsilon-acetyl-Lys-
tRNA
reacted only slightly with puromycin at either 10 or 30 mM Mg2+. When Lys-tRNAE. coli or Nepsilon-acetyl-Lys-tRNAE. coli were added to rabbit reticulocyte cell-free protein synthesizing incubations, the incorporation of either amino acid into protein was complete within 5 min. The final incorporation level of the analogue was 82% that of the unmodified lysine. After protein synthesized in the presence of Nepsilon-acetyl-[14C]Lys-
tRNA
had been digested enzymatically to single amino acids, ion-exchange chromatography and paper electrophoresis showed that nearly all of the radioactivity was present as Nepsilon-acetyllysine.
Gel
filtration of the post-ribosomal supernatant revealed that most of the Nepsilon-acetyllysine radioactivity cochromatographed with tetrameric hemoglobin.
...
PMID:Nepsilon-acetyllysine transfer ribonucleic acid: a biologically active analogue of aminoacyl transfer ribonucleic acids. 76 30
1. A modification of the RPC 1 system of A.D. Kelmers, G.D. Novelli & M.P. Stulberg (1965) (J. Biol. Chem. 240, 3979-3983) is described in which the support medium is a Celite of narrow range particle size treated with dichlorodimethylsilane. 2. By using this system an apparently pure preparation of
tRNA
Cys was isolated from baker's yeast
tRNA
. 3. This preparation accepted at least 60% of the theoretical quantity of [3-14C]cysteine in a conventional assay and failed to accept isoleucine, phenylalanine, proline, serine or tyrosine. 4. A theoretical countercurrent-distribution curve calculated by assuming a distribution coefficient K of 2.03 was in excellent agreement with the profiles of E260 and cysteine-acceptor ability after 537 transfers in the 1.85 M-phosphate/formamide/propan-2-ol system of C.M. Connelly & B.P. Doctor (1965) (J. Biol. Chem. 241, 715-719). 5. Chromatography of
tRNA
Cys on Bio-
Gel
P100 polyacrylamide beads afforded two components one of which was far less efficient than the other in accepting cysteine. The base compositions of the two were similar.
...
PMID:The extraction and purification of a cysteine transfer ribonucleic acid from baker's yeast. 77 75
Full-length and 5'-truncated variants of human (h)
tRNA
(UUULys3) were synthesized by in vitro transcription using SP6 RNA polymerase. Bovine(b)
tRNA
(SUULys3) was purified from calf liver. Both full-length
tRNA
species were shown to be biologically active in an aminoacylation assay.
Gel
retardation assays revealed that both full-length
tRNA
species, as well as a 5'-truncated h-
tRNA
(UUULys3) molecule containing 24 nucleotides (nt) at the 3' end (Lys24), interact with human immunodeficiency virus (HIV)-1 reverse transcriptase (RT). Competition studies with these three
tRNA
species demonstrate that the 3' end of h-
tRNA
(UUULys3) contributes to the interaction with HIV-1 RT. Escherichia coli
tRNA
(UUULys) and
tRNA
(UUCGlu2) were also able to interact with the enzyme, whereas unrelated RNA molecules such as E. coli 5S rRNA did not bind to RT. Both b-
tRNA
(SUULys3) and h-
tRNA
(UUULys3) molecules, as well as the 5'-truncated variants, could be demonstrated to prime cDNA synthesis specifically using a HIV-1 RNA template, prepared by in vitro transcription, indicating that other viral or cellular proteins are not essential for this process. E. coli
tRNA
(UUULys) and
tRNA
(UUCGlu2), although able to interact with HIV-1 RT, failed to prime retroviral transcription. Products of cDNA synthesis were characterized by polymerase chain reaction, demonstrating that at least 18 nt at the 3' ends of h-
tRNA
(UUULys3) and b-
tRNA
(SUULys3) are still present in the cDNA product, whereas the 5' ends of both primer molecules were removed by the RNase H activity of HIV-1 RT.
...
PMID:Synthetic human tRNA(UUULys3) and natural bovine tRNA(UUULys3) interact with HIV-1 reverse transcriptase and serve as specific primers for retroviral cDNA synthesis. 137 59
The interaction of several forms (p51, p66, and p66/p51) of recombinant human immunodeficiency virus type 1 reverse transcriptase (HIV-1 RT) with a synthetic derivative of its cognate replication primer,
tRNA
(Lys-3), has been determined by gel-mobility shift analysis. While p66/p51 RT is proficient in
tRNA
binding, preparations of p66 and p51 display only weak binding at elevated protein:
tRNA
ratios, despite the former containing both RNA-dependent DNA polymerase and ribonuclease H (RNase H) activity.
Gel
permeation analysis of purified p66 RT indicate this to be predominantly monomeric, suggesting that dimerization may be a prerequisite for efficient
tRNA
binding. Prolonged incubation of a mixture of the 66- and 51-kDa polypeptides results in heterodimer reconstitution, restoration of
tRNA
binding, and recovery of appreciable levels of RNA-dependent DNA polymerase activity. Under the same conditions, both the
tRNA
binding and RNA-dependent DNA polymerase activities of the 66- and 51-kDa polypeptides are unaffected, suggesting that they remain in the monomeric conformation.
...
PMID:Interaction of tRNA(Lys-3) with multiple forms of human immunodeficiency virus reverse transcriptase. 137 42
2'-Fluoro- and 2'-amino-2'-deoxynucleoside 5'-triphosphates have been investigated as substrates for T7 RNA polymerase. Michaelis-Menten kinetic parameters are reported for the incorporation of 2'-fluoro-2'-deoxyuridine, 2'-fluoro-2'-deoxycytidine, and 2'-amino-2'-deoxyuridine into runoff transcripts. The 2'-amino derivative of uridine is a better substrate than the 2'-fluoro derivative.
Gel
electrophoretic analysis shows that full-length transcripts with a length of 2500 nucleotides can be obtained with the analogues, although a considerable amount of shorter fragments accompanies the full-length product. In keeping with the kinetic analysis, the 2'-aminouridine triphosphate gives a cleaner product than the 2'-fluoro analogue. Transcription of two
tRNA
genes shows that such shorter templates can be transcribed to full-length products essentially without premature termination with any of the analogues.
...
PMID:2'-Fluoro- and 2'-amino-2'-deoxynucleoside 5'-triphosphates as substrates for T7 RNA polymerase. 139 Jul 41
1
2
3
4
5
6
7
8
9
Next >>